Life sciences expert Jennie Taveras has joined STO Building Group to lead the company’s growth in the life sciences sector ...
The company is paying China-based biotech LaNova Medicines $588 million for the kind of dual-pronged antibody drug that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback